| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 04/04/2002 | US20020039738 Separating probes from label; obtain sample, apply charge to sample, separate probe from phosphate detectable structures, recover probes |
| 04/03/2002 | EP1192981A1 Desulfurizing agent and method for desulfurization of hydrocarbon |
| 04/03/2002 | EP1192170A1 Propargyl phenyl ether a2a receptor agonists |
| 04/03/2002 | EP1192169A2 C-pyrazole a2a receptor agonists |
| 04/03/2002 | CN1343213A 2,3-0-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors |
| 04/02/2002 | US6365374 2′-deoxy-2′-alkylnucleotide containing nucleic acid |
| 04/02/2002 | US6365341 Stabilization of highly sensitive nucleic acid stains in aqueous solutions |
| 04/02/2002 | US6365179 Conjugate having a cleavable linkage for use in a liposome |
| 03/28/2002 | WO2001077075A3 Inhibitors of inflammation and reperfusion injury |
| 03/28/2002 | WO2001064958A3 Modified oligonucleotides for mismatch discrimination |
| 03/28/2002 | WO2001049687A3 Cyclohexene nucleic acids |
| 03/28/2002 | US20020037873 Biologically active phosphotriester-type compounds |
| 03/28/2002 | US20020037872 N6 heterocyclic 5' modified adenosine derivatives |
| 03/27/2002 | EP1189916A2 N-pyrazole a 2a receptor agonists |
| 03/27/2002 | EP1189908A1 Indolocarbazole alkaloids from a marine actinomycete |
| 03/26/2002 | US6362329 Process to prepare pyrimidine nucleosides |
| 03/26/2002 | US6362323 Non-nucleotide containing nucleic acid |
| 03/26/2002 | US6362168 Antiparasitic agents |
| 03/21/2002 | WO2002022630A1 Purine derivatives |
| 03/21/2002 | WO2001068661A3 Crystalline alkycycline derivative |
| 03/21/2002 | WO2001068034A3 1, 2, 4-triazoloribonucleoside prodrugs and their administration to treat viral disease conditions |
| 03/21/2002 | WO2001043731A3 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage |
| 03/21/2002 | US20020035086 Acylated uridine and cytidine and uses thereof |
| 03/21/2002 | US20020035085 Administering a 2'-deoxy-beta-L-erythro-pentofuranonucleoside or a pharmaceutically acceptable salt or prodrug thereof |
| 03/21/2002 | US20020035077 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 03/21/2002 | US20020034761 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 03/21/2002 | US20020034473 Nucleosides for imaging and treatment applications |
| 03/19/2002 | US6358963 For therapy of viral infections |
| 03/19/2002 | US6358934 Administering viricide to treat human t-cell leukemia/lymphoma and hepatitis virus infections; acquired immunodeficiency syndrome (aids) treatment |
| 03/19/2002 | US6358931 Oligonucletide conjugated to imidazole; intercalation and coordination compounds; medical diagnosis, gene therapy; antisense agents |
| 03/19/2002 | US6358689 Detection of markers in nascent proteins |
| 03/19/2002 | US6358684 Hybridizing nucleic acid sequence with fluorescently labeled oligonucleotide primer in presence of deoxynucleoside triphosphates, dideoxynucleoside triphosphate and dna polymerase, fluorescently measuring mixture formed to sequence |
| 03/14/2002 | WO2002021098A2 A method for identifying polymorphisms |
| 03/14/2002 | WO2002020843A1 A method for sequencing nucleic acid sequences without chain termination |
| 03/14/2002 | WO2002020842A1 System, method and apparatus for transgenic and targeted mutagenesis screening |
| 03/14/2002 | WO2002020540A1 Adenosine derivatives and use thereof |
| 03/14/2002 | WO2002020539A1 Adenosine derivatives and use thereof |
| 03/14/2002 | WO2002020538A2 Stavudine polymorphic form 1 process |
| 03/14/2002 | WO2002020537A2 Linker phosphoramidites for oligonucleotide synthesis |
| 03/14/2002 | WO2002020150A2 Photocleavable protecting groups |
| 03/14/2002 | WO2002020024A1 Purine ribosides as antiarrhythmics |
| 03/14/2002 | US20020032362 Method of manufacturing a soft hearing aid |
| 03/14/2002 | US20020032168 Purine derivatives |
| 03/14/2002 | US20020032164 For sanitizing surfaces |
| 03/14/2002 | CA2421732A1 Photocleavable protecting groups |
| 03/14/2002 | CA2421266A1 Linker phosphoramidites for oligonucleotide synthesis |
| 03/14/2002 | CA2421067A1 Adenosine derivatives and use thereof |
| 03/13/2002 | EP1186612A1 Process for the preparation of cytidine derivatives |
| 03/13/2002 | EP1185542A2 Purine derivatives |
| 03/13/2002 | CN1339440A Process for producing super critical extracting caterpillar fungus deoxynucleoside |
| 03/12/2002 | US6355810 Multibinding inhibitors of HMG-CoA reductase |
| 03/12/2002 | US6355787 Reaction of alkene with purine base in the presence of palladium catalyst |
| 03/12/2002 | US6355432 Collection of plurality of beads which have binding polymers of different target specific sequence attached thereto; said beads being coded with encoding system whereby target specific sequence of polymer attached to beads can be identified |
| 03/12/2002 | US6354990 Soft hearing aid |
| 03/07/2002 | WO2002018406A1 Alkylated hexitol nucleoside analogues and oligomers thereof |
| 03/07/2002 | WO2002018405A2 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives |
| 03/07/2002 | WO2002018404A2 Nucleoside derivatives for the treatment of hepatitis c |
| 03/07/2002 | WO2002018388A1 Novel nucleoside analogs and oligonucleotide derivatives containing these analogs |
| 03/07/2002 | WO2002018371A1 Nucleoside metabolism inhibitors |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028790 Use of agonists or antagonists of P2 purinoceptors for the prevention glutamate-evoked cytotoxicity |
| 03/07/2002 | US20020028787 Nervous system disorders; administering exogenous uridine compound |
| 03/07/2002 | US20020028519 Preferential detection of particle in sample; obtain sample, expose to light source, detect scattered light with eye, visibily scattered light indicates preferential particles in sample |
| 03/07/2002 | US20020028473 Components of dense microspheres derived from mammalian brain tissue detectable in cerebrospinal fluid |
| 03/07/2002 | US20020028442 Libraries of preferential particles; for use in in vitro evolution of nucleic aptamers; for use drug screening and development of disease resistant plants |
| 03/07/2002 | CA2419399A1 Nucleoside derivatives for the treatment of hepatitis c |
| 03/06/2002 | EP1183369A1 Polyketides and their synthesis |
| 03/06/2002 | EP1183091A1 Optimization of ligand affinity for rna targets using mass spectrometry |
| 03/06/2002 | CN1338461A Arbinosyl furanuridine compound and its preparing process |
| 02/28/2002 | WO2002016382A1 Improved specificity in treatment of diseases |
| 02/28/2002 | WO2002016381A2 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | WO2002015904A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| 02/28/2002 | US20020025943 Nucleoside analog compositions and uses thereof |
| 02/28/2002 | US20020025922 AZT derivatives exhibiting spermicidal and anti-viral activity |
| 02/28/2002 | CA2420179A1 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | CA2416748A1 Improved specificity in treatment of diseases |
| 02/28/2002 | CA2415793A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| 02/27/2002 | EP1181335A1 Extended rhodamine compounds useful as fluorescent labels |
| 02/27/2002 | EP1181302A1 Orally active a1 adenosine receptor agonists |
| 02/27/2002 | EP1181301A1 Oligonucleotide synthesis with lewis acids as activators |
| 02/27/2002 | EP1181291A2 Dna methyltransferase inhibitors |
| 02/27/2002 | EP0927178B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/27/2002 | CN1337401A Thiophosphoryl amino acid ester compound and its prepn process |
| 02/26/2002 | US6350873 Process for preparing 5′-acetylstavudine |
| 02/26/2002 | US6350863 3, 4-di(acylamino)phenyl ribofuranosides, 2'-deoxyribofuranosides, and methods of making |
| 02/26/2002 | US6350736 phenyl methoxyalaninyl phosphate derivatives of 2',3'-didehydro-2',3'-dideoxythymidine with an electron-withdrawing moiety, such as p-bromo, for enhanced hydrolysis, have increased potency without high cytotoxic activity; inhibitors of HIV reverse transcriptase; thymidine-kinase (TK)-deficient cells |
| 02/26/2002 | US6350735 Purine derivatives |
| 02/26/2002 | CA2072484C Use of nadh or nadph against cancer and aids |
| 02/21/2002 | WO2002014340A1 Processes for the preparation of oligonucleotides_______________ |
| 02/21/2002 | US20020022722 4'-C-ethynyl pyrimidine nucleoside compounds |
| 02/21/2002 | US20020022600 Azt derivatives exhibiting spermicidal and anti-viral activity |
| 02/21/2002 | US20020022001 Nucleosides for imaging and treatment applications |
| 02/20/2002 | EP1180112A1 Detection using degradation of a tagged sequence |
| 02/20/2002 | CN1336933A Protecting groups for carbohydrate synthesis |
| 02/19/2002 | US6348596 Non-fluorescent asymmetric cyanine dye compounds useful for quenching reporter dyes |
| 02/19/2002 | US6348589 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
| 02/19/2002 | US6348587 Purine or pyrimidine base derivatives; anticancer, antitumor and antiproliferative agents; treating hiv and hepatitis |
| 02/19/2002 | US6348583 Nucleobase containing polythioethers synthesized on polyethylene glycol, succinic anhydride and propylamine modified glass; nucleic acid mimetics |
| 02/19/2002 | US6348451 Acyl deoxyribonucleoside derivatives and uses thereof |
| 02/14/2002 | WO2002012264A1 Process for producing 2'-o-alkylguanosine |